KAI 9803

Known as: KAI-9803, KAI9803 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2011
01220072011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
KAI-9803 is composed of a selective δ-protein kinase C (δPKC) inhibitor peptide derived from the δV1-1 portion of δPKC (termed… (More)
Is this relevant?
2011
2011
Unstable drug candidates often lead to complexity for both sample collection and bioanalysis. Dried blood spot (DBS) technology… (More)
Is this relevant?
2008
2008
BACKGROUND KAI-9803, a delta-protein kinase C inhibitor, has been shown to ameliorate injury associated with ischemia and… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2008
2008
“Intracoronary KAI-9803 as an Adjunct to Primary Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction” To… (More)
Is this relevant?
2008
2008
  • 2008
Background—KAI-9803, a -protein kinase C inhibitor, has been shown to ameliorate injury associated with ischemia and reperfusion… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2008
2008
  • 2008
Background—KAI-9803, a -protein kinase C inhibitor, has been shown to ameliorate injury associated with ischemia and reperfusion… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
  • sind geplant.
  • Herz Kardiovaskuläre Erkrankungen
  • 2007
KAI-9803 ist ein selektiver kompetitiver Inhibitor der Proteinkinase Cd, welcher an der Entstehung eines Reperfusionsschadens… (More)
Is this relevant?